The growth of Oligonucleotide Synthesis Market is mainly driven by the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.
The global oligonucleotide synthesis market is expected to reach USD 2.46 Billion by 2022 from USD 1.47 Billion in 2017 at a CAGR of 10.9%.
This report segments the market into product, application, end user, and region.
“Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) – Global Forecast to 2022”
Key Players
The oligonucleotide synthesis market is highly competitive with the presence of several small and big players. Prominent players in the market include Agilent Technologies (US), ATDBio (UK), Bio-Synthesis (US), BioAutomation (US), LGC Biosearch Technologies (US), Eurofins Genomics (Germany), Eurogentec (Belgium), GeneDesign (Japan), GE Healthcare (US), GenScript (US), Integrated DNA Technologies (IDT) (US), Nitto Denko Avecia (US), Thermo Fisher Scientific (US), TriLink Biotechnologies (US), and Sigma-Aldrich Corporation (Sigma-Aldrich) (US) (part of Merck KGAA (Germany)).
Target Audience for this Report:
- Life science instrumentation and reagent companies
- Pharmaceutical and biotechnology companies
- Hospitals and clinics
- Academic researchers and government research organizations
- Private research institutes
- Custom oligonucleotide service providers
- Contract manufacturing organizations (CMOs)
To Know More @ https://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html
